from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0760c/-

LFCtreatmentdescriptionclass of inhibitor

-0.993

Amikacinug/mL Amikacintranslation

-0.932

Cap5-10ug/mL Capreomycintranslation

-0.144

Rox10-50 ug/mL Roxithromycintranslation

0.485

SM2-5 ug/mL Streptomycintranslation

-1.270

Tet5-10 ug/mL Tetracyclinetranslation

-0.196

Rif0.2-5ug/mL Rifampicintranscription

-0.114

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.574

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.441

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.959

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.027

Clofazimine10-13 ug/mL Clofaziminerespiration

0.250

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.406

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.403

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.280

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.132

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.706

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.234

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.306

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.222

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.370

KCN5-20 ug/mL Potassium cyaniderespiration

-0.612

NaN30.2-2 mM Sodium aziderespiration

0.560

Nigericin50 uM Nigericinrespiration

-1.085

TRC10-150 ug/mL Triclosanrespiration

-1.366

TRZ10-25 ug/mL Thioridazinerespiration

-2.609

Valinomycin0.5-10 uM Valinomycinrespiration

1.187

ZnSO42 mM ZnSO4respiration

-0.375

menadione6-10 ug/mL Menadionerespiration

-0.231

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.386

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.030

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.148

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.846

NRP_1Non-replicating persistence stage 1dosRassociated

0.535

Amp0.2mg/mL AmpicillincellWall

0.454

Cephalexin20-100 ug/mL CephalexincellWall

0.010

Cerulenin0.32-5 ug/mL CerulenincellWall

0.941

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.473

EMB10-20 ug/mL EthambutolcellWall

0.162

Eta12-40 ug/mL EthionamidecellWall

0.252

INH0.2-0.4 ug/mL IsoniazidcellWall

0.499

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.406

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.566

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.168

BZA0.12 mg/mL BenzamidearomaticAmides

0.171

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.231

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.554

H2O24 mM hydrogen peroxideDNAdamaging

-0.850

Levo10 ug/mL LevofloxacinDNAdamaging

0.952

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.184

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.027

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.703

UVUV-irradiationDNAdamaging

-0.756

ARP41-4 ug/mL Antitubercular compound ARP4?

0.879

Antimycin12.5-50 ug/mL Antimycin A?

0.502

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.707

PA_110-50 ug/mL Antitubercular compound PA-1?

1.104

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.829

PA8240.2-2 ug/mL PA-824?

-0.846

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.135

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.188

Verapamil50 uM Verapamil?

0.508

mercaptoethanol2 mM 2-Mercaptoethanol?

0.133

methoxatin10-20 ug/mL Methoxatin?